Recent Jobs

  • Regulatory Affairs Associate Director

    Middlesex, London, Hertfordshire, Buckinghamshire, Berkshire, >UK
    • FULL_TIME
  • Senior Regulatory Affairs Specialist

    Hertfordshire, Hampshire, Essex, Buckinghamshire, Berkshire, >UK
    • FULL_TIME
  • Regulatory Affairs Officer – Compliance (France)

    France, EU
    • FULL_TIME
  • Regulatory Affairs Officer Senior Officer

    London, Hertfordshire, Hampshire, Buckinghamshire, Berkshire, >UK
    • FULL_TIME
Load more listings

Featured Job

Regulatory Affairs Associate Director

Reference Number: J26115 Regulatory Affairs Associate Director Locations: Buckinghamshire Salary: £70,000 – £85,000 + Competitive Benefits package Reference Number: J26115

Make your job search easier

Create a candidate account to save jobs for later and have the latest roles and career advice emailed to you.

Register for Job Alerts

Create an Account

Complete your online profile and make it easier to apply for roles on the move.

Register your Details

Want to see how you compare to the rest of the industry?

Enter your details to receive a complimentary copy of our salary guide delivered to your door.

Life Science Salary Guide

Regulatory Professionals is one of the fastest growing global integrated regulatory outsourcing providers with a network of 20,000 pharmaceutical professionals globally. Working exclusively within the regulatory functions of Pharmaceutical, Biotechnology, Medical Device, Consumer health / OTC and Diagnostics industries.

Our integrated regulatory affairs recruitment team is there to support partner organisations of all sizes. Ranging for one regulatory consultant, to deliver a specialist project, to outsourcing functional regulatory teams of over 100+, Regulatory Professionals are able to offer global support partnered with expert local knowledge. Our capabilities also offer contract and permanent regulatory staffing services to allow a 360 degree service range for all aspects of regulatory delivery.

Our regulatory recruitment teams approach is tailored to meet the needs of our partners requirements allowing you to shift internal R&D focus to more strategic activities to improve lifecycle performance.

The benefits of Regulatory Professionals integrated teams are measured not just in the savings that could result in multi-mullion dollar cost reductions, but equally in understanding that delays in any part of the regulatory cycle affect the ability to give patients access to transformational products.

Our integrated teams support your product portfolio by giving you flexibility of resource at the peaks and troughs of the product life cycle, while ensuring you maintain control of strategic regulatory departments. This is supported by consistent, measurable and tracked metrics to maximise accountability.

To find out more about each of the regulatory areas we specialise in, take a look at the following regulatory recruitment services:

•    Regulatory Medical Devices
•    Regulatory Clinical
•    Regulatory CMC
•    Regulatory Submissions and Publishing
•    Regulatory Writing
•    Lifecycle Management

Our experienced specialist recruitment consultants are available to speak to you confidentially about our outsourcing regulatory affairs services. To find out more information or to discuss any of our regulatory vacancies, please call our specialist regulatory affairs recruitment team.

+44 (0)118 9522 797

Contact us today to find out how we can progress your career to the next level

Latest News

EU approve Gedeon’s novel antipsychotic for schizophrenia

European regulators have approved Gedeon Richter’s novel antipsychotic Reagila as a new option for the treatment of patients with schizophrenia. In clinical trials the drug, a potent dopamine D3/D2 receptor partial agonist atypical antipsychotic, significantly improved symptoms of the condition and reduced the risk of relapse by 55% when compared to the placebo.

Continue Reading

eu_skinny

Hunt and Clark look to clarify drug regulation in the UK after Brexit.

Jeremy Hunt, Health Secretary, and Greg Clark, Business Secretary, have recently made a bold move to suggest that the UK will consider collaborating closely with the EU in order to navigate drug approvals post-Brexit. The pharmaceutical industry has been insistent since the referendum for clearer indication of the future of drug regulation post Brexit decision

Continue Reading